A molecular variant of angiotensinogen is associated with idiopathic intrauterine growth restriction

Obstetrics and Gynecology

Volumn 101, Issue 2, 2003, Pages 237-242

  Zhang, Xiu Quan ^a   Varner, Michael ^a   Dizon Townson, Donna ^a   Song, Francis ^a   Ward, Kenneth ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; ANGIOTENSINOGEN; DNA; METHIONINE; THREONINE;

ADULT; ALLELE; ARTICLE; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MOLECULAR BIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK FACTOR;

ADOLESCENT; ADULT; ALLELES; ANGIOTENSINOGEN; BASE SEQUENCE; CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; GENE FREQUENCY; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PRENATAL DIAGNOSIS; PREVALENCE; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VARIATION (GENETICS);

EID: 0037308655     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02512-7     Document Type: Article

References (29)

1. Bernstein I., Gabbe S.G. Intrauterine growth restriction. Gabbe S.G., Niebyl J.R., Simpson J.L., Annas G.J. Obstetrics: Normal and problem pregnancies. 3rd ed:1996;863-886 Churchill-Livingstone, New York.
2. Nogami H., Yokose T., Tachibana T. Regulation of growth hormone expression in fetal rat pituitary gland by thyroid or glucocorticoid hormone. Am J Physiol. 268:1995;E262-267.
3. Amante A., Borgiani P., Gimelfarb A., Gloria-Bottini F. Interethnic variability in birth weight and genetic background A study of placental alkaline phosphatase . Am J Phys Anthropol. 101:1996;449-453.
4. Khong T.Y., De Wolf F., Robertson W.B., Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 93:1986;1049-1059.
5. Salafia C.M., Vogel C.A., Bantham K.F., Vintzileos A.M., Pezzullo J., Silberman L. Preterm delivery Correlations of fetal growth and placental pathology . Am J Perinatol. 9:1992;190-193.
6. Morgan T., Craven C., Lalouel J.-M., Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol. 180:1999;95-102.
7. Ward K., Hata A., Jeunemaitre X., Helin C., Nelson L., Namikawa C., et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 4:1993;59-61.
8. Olson A.L., Perlman S., Robillard J.E. Developmental regulation of angiotensinogen gene expression in sheep. Pediatr Res. 28:1990;183-185.
9. Piper J.M., Xenakis E.M., McFarland M., Elliott B.D., Berkus M.D., Langer O. Do growth-retarded premature infants have different rates of perinatal morbidity and mortality than appropriately grown premature infants? Obstet Gynecol. 87:1996;169-174.
10. Dashe J.S., McIntire D.D., Lucas M.J., Leveno K.J. Effects of symmetric and asymmetric fetal growth on pregnancy outcomes. Obstet Gynecol. 96:2000;321-327.
11. Savitz D.A., Ananth C.V., Berkowitz G.S., Lapinski R. Con-cordance among measures of pregnancy outcome based on fetal size and duration of gestation. Am J Epidemiol. 151:2000;627-633.
12. Joern H., Rath W. Comparison of Doppler sonographic examinations of the umbilical and uterine arteries in high-risk pregnancies. Fetal Diagn Ther. 13:1998;150-153.
13. Gruenwald P. Growth of the human fetus. I. Normal growth and its variation. Am J Obstet Gynecol. 94:1966;1112-1119.
14. Keirse M.J. Epidemiology and aetiology of the growth retarded baby. Clin Obstet Gynaecol. 11:1984;415-436.
15. Casalino M. Intrauterine growth restriction A neonatologist's approach . J Reprod Med. 14:1975;248-250.
16. Meredith H.V. Body weight at birth of viable human infants A worldwide comparative treatise . Hum Biol. 42:1970;217-264.
17. Cooper A.C., Robinson G., Vinson G.P., Cheung W.T., Broughton Pipkin F. The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy. Placenta. 20:1999;467-474.
18. Rotimi C., Cooper R., Ogunbiyi O., Morrison L., Ladipo M., Tewksbury D., et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation. 95:1997;2348-2350.
19. Vandenbosche R.C., Kirchner J.T. Intrauterine growth restriction. Am Fam Physician. 58:1998;1384-1390., 1393-4.
20. Macara L., Kingdom J.C., Kaufmann P., Kohnen G., Hair J., More I.A., et al. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta. 17:1996;37-48.
21. Roberts R. Pregnancy related hypertension. Resnik R. Maternal fetal medicine: Principles and practice. 1989;777-823 W.B. Saunders, Philadelphia.
22. Redman C.W. Current topics Pre-eclampsia and the placenta . Placenta. 12:1991;301-308.
23. Tenney B. Placenta in toxemia of pregnancy. Am J Obstet Gynecol. 39:1940;10000-10005.
24. Schweikhart G., Kaufmann P., Beck T. Morphology of placental villi after premature delivery and its clinical relevance. Arch Gynecol. 239:1986;101-114.
25. Kingdom J.C., Kaufmann P. Oxygen and placental vascular development. Adv Exp Med Biol. 474:1999;259-275.
26. Salas S.P., Rosso P., Espinoza R., Robert J.A., Valdes G., Donoso E. Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth restriction. Obstet Gynecol. 81:1993;1029-1033.
27. Morgan T., Craven C., Nelson L., Lalouel J.M., Ward K. Angiotensinogen Thr235 expression is elevated in decidual spiral arteries. J Clin Invest. 100:1997;1406-1415.
28. Rai R., Regan L. Obstetric complications of antiphospholipid antibodies. Curr Opin Obstet Gynecol. 9:1997;387-390.
29. Stallmach T., Hebisch G., Joller-Jemelka H.I., Orban P., Schwaller J., Engelmann M. Cytokine production and visualized effects in the feto-maternal unit. Quantitative and topographic data on cytokines during intrauterine disease. Lab Invest. 73:1995;384-392.